Rxo (RXO) Operating Expenses (2021 - 2026)

Rxo (RXO) has reported Operating Expenses for 6 consecutive years, with $197.0 million the latest figure, recorded in Q1 2026.

• Operating Expenses for Q1 2026 came in at $197.0 million, down 6.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $819.0 million (up 12.04% YoY), and the FY2025 annual result was $832.0 million, up 24.92% from the prior year.
• Operating Expenses was $197.0 million for Q1 2026 at Rxo, down from $200.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at $218.0 million in Q4 2024 and troughed at $144.0 million in Q2 2023.
• Average Operating Expenses over 5 years is $172.1 million, with a median of $158.0 million recorded in 2022.
• Year-over-year, Operating Expenses declined 13.25% in 2023 and soared 49.32% in 2024.
• Over 5 years, Operating Expenses stood at $155.0 million in 2022, then fell by 5.81% to $146.0 million in 2023, then jumped by 49.32% to $218.0 million in 2024, then dropped by 8.26% to $200.0 million in 2025, then slipped by 1.5% to $197.0 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $197.0 million in Q1 2026, $200.0 million in Q4 2025, and $208.0 million in Q3 2025.